NCT02333929View on ClinicalTrials.gov

Validation of Rivaroxaban Assay for US Registration

CompletedOBSERVATIONAL

Enrollment

100

Participants

Timeline

Start Date

March 31, 2015

Primary Completion Date

December 31, 2016

Study Completion Date

December 31, 2016

Conditions

Patients Receiving Rivaroxaban Treatment

Interventions

DEVICE

STA- Rivaroxaban Calibrator&Control

One sample blood collected per patient the day of the treatment (drawn soon after the the drug intake)

Trial Locations (1)

18101

Lehigh Valley Health Nrwork, Allentown

Sponsors

Lead Sponsor

Diagnostica Stago

All Listed Sponsors

lead

Diagnostica Stago

INDUSTRY